Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Testing effectiveness (Phase 2)Ended earlyNCT00276744
What this trial is testing

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 249
Not applicableStudy completedNCT02983500
What this trial is testing

Patient Reported Outcomes Registry in Patient With Cancer Cachexia

Who this might be right for
Metastatic Pancreatic CancerNSCLC, Metastatic
iOMEDICO AG 253
Testing effectiveness (Phase 2)WithdrawnNCT03509298
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Large-scale testing (Phase 3)Study completedNCT01231347
What this trial is testing

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasAdvanced Solid TumorsCancer+13 more
NantCell, Inc. 800
Not applicableUnknownNCT04082455
What this trial is testing

Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06736717
What this trial is testing

Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Kansas Medical Center 16
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Early research (Phase 1)Active Not RecruitingNCT05497778
What this trial is testing

A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.

Who this might be right for
Pancreas Cancer
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT02581215
What this trial is testing

Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Walid Shaib, MD 84
Testing effectiveness (Phase 2)Study completedNCT00417976
What this trial is testing

Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Tony Bekaii-Saab 42
Testing effectiveness (Phase 2)Study completedNCT04825288
What this trial is testing

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
XBiotech, Inc. 76
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT04923529
What this trial is testing

TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
The University of Hong Kong 28
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Not applicableStudy completedNCT02079623
What this trial is testing

Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Aalborg University Hospital 33
Early research (Phase 1)Study completedNCT01834170
What this trial is testing

EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University of Tehran 12
Next Page